DE69707296T2 - Melanom-assoziierte peptid-analogen und impfstoffe gegen melanom - Google Patents

Melanom-assoziierte peptid-analogen und impfstoffe gegen melanom

Info

Publication number
DE69707296T2
DE69707296T2 DE69707296T DE69707296T DE69707296T2 DE 69707296 T2 DE69707296 T2 DE 69707296T2 DE 69707296 T DE69707296 T DE 69707296T DE 69707296 T DE69707296 T DE 69707296T DE 69707296 T2 DE69707296 T2 DE 69707296T2
Authority
DE
Germany
Prior art keywords
melanoma
associated peptide
vaccines against
peptide analogs
ctl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69707296T
Other languages
English (en)
Other versions
DE69707296D1 (de
Inventor
Gustav Figdor
Jan Adema
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, US
Original Assignee
Introgene BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Introgene BV filed Critical Introgene BV
Application granted granted Critical
Publication of DE69707296D1 publication Critical patent/DE69707296D1/de
Publication of DE69707296T2 publication Critical patent/DE69707296T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69707296T 1996-07-11 1997-07-08 Melanom-assoziierte peptid-analogen und impfstoffe gegen melanom Expired - Lifetime DE69707296T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96201945 1996-07-11
PCT/EP1997/003712 WO1998002538A1 (en) 1996-07-11 1997-07-08 Melanoma associated peptide analogues and vaccines against melanoma

Publications (2)

Publication Number Publication Date
DE69707296D1 DE69707296D1 (de) 2001-11-15
DE69707296T2 true DE69707296T2 (de) 2002-07-25

Family

ID=8224171

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69707296T Expired - Lifetime DE69707296T2 (de) 1996-07-11 1997-07-08 Melanom-assoziierte peptid-analogen und impfstoffe gegen melanom

Country Status (10)

Country Link
EP (1) EP0934405B1 (de)
JP (2) JP4386463B2 (de)
AT (1) ATE206759T1 (de)
AU (1) AU3693897A (de)
CA (1) CA2259944C (de)
DE (1) DE69707296T2 (de)
ES (1) ES2165619T3 (de)
ID (1) ID18726A (de)
WO (1) WO1998002538A1 (de)
ZA (1) ZA975858B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040156861A1 (en) 1996-07-11 2004-08-12 Figdor Carl Gustav Melanoma associated peptide analogues and vaccines against melanoma
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma
FR2763071B1 (fr) * 1997-05-07 2003-05-16 Centre Nat Rech Scient Analogues peptidiques, et leurs utilisations notamment dans des compositions pharmaceutiques et pour le diagnostic
CA2295321C (en) * 1997-06-23 2008-01-29 Ludwig Institute For Cancer Research Isolated nona- and decapeptides which bind to hla molecules, and the use thereof
AU1013601A (en) 1999-10-22 2001-05-08 Aventis Pasteur Limited Method of inducing and/or enhancing an immune response to tumor antigens
EP1359937A4 (de) * 2001-02-14 2004-07-28 Genzyme Corp Veränderte peptidliganden
EP2102236B1 (de) 2007-01-12 2014-08-06 Government of the United States of America, Represented by the Secretary, Department of Health and Human Services GP100-spezifische T-Zellen-Rezeptoren sowie entsprechende Materialien und Verwendungsverfahren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE272113T1 (de) * 1994-02-16 2004-08-15 Crucell Holland Bv Melanoma-assoziierte antigene, epitope davon und impstoffe gegen melanoma
CA2188432C (en) * 1994-04-22 2011-02-01 Yutaka Kawakami Melanoma antigens
ZA975858B (en) * 1996-07-11 1998-09-01 Akzo Nobel Nv Melanoma associated peptide analogues and vaccines against melanoma

Also Published As

Publication number Publication date
JP2009178166A (ja) 2009-08-13
ZA975858B (en) 1998-09-01
ID18726A (id) 1998-05-07
ES2165619T3 (es) 2002-03-16
DE69707296D1 (de) 2001-11-15
EP0934405A1 (de) 1999-08-11
ATE206759T1 (de) 2001-10-15
AU3693897A (en) 1998-02-09
CA2259944A1 (en) 1998-01-22
CA2259944C (en) 2011-06-28
WO1998002538A1 (en) 1998-01-22
JP2000515739A (ja) 2000-11-28
EP0934405B1 (de) 2001-10-10
JP5198354B2 (ja) 2013-05-15
JP4386463B2 (ja) 2009-12-16

Similar Documents

Publication Publication Date Title
DE69533295D1 (de) Melanoma-assoziierte Antigene, Epitope davon und Impstoffe gegen Melanoma
BR9306984A (pt) Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
CO4810234A1 (es) Vacunas para el tratamiento de virus papiloma humano
CY1114722T1 (el) Αντιγονα στρεπτοκοκκου
ATE131067T1 (de) Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei schweinen (prrs) und diagnose.
TR200100936T2 (tr) Terapötik aşılama
PT1587532E (pt) Péptidos derivados de survivina e a sua utilização
HK1093314A1 (en) Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens
CN100381463C (zh) 用于生产治疗用乙型肝炎疫苗或药物的免疫原及其制备方法和用途
SE8700805D0 (sv) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas
DE69707296T2 (de) Melanom-assoziierte peptid-analogen und impfstoffe gegen melanom
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
ATE344052T1 (de) Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt.
AU2003241127A8 (en) Membrane-anchored beta2 microglobulin covalently linked to mhc class i peptide epitopes
HU9200583D0 (en) Method for producing el peptides of rubeola
Guohua et al. Development of an anticomplement immunoenzyme test for detection of EB virus nuclear antigen (EBNA) and antibody to EBNA
ATE482974T1 (de) Multimere peptide, die auf dem hepatitis c virus hüllprotein basieren, für diagnostische verwendung und für impfzwecke
SE8700466D0 (sv) Vaccines against melanoma
Lucchese et al. protEomic pEptidE scan of porphyromonas gingiValis fima typE ii for sEarching potEntial b-cEll EpitopEs
EP1502602A3 (de) Verfahren zur therapeutischen Impfung
ZA888580B (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
Kolesanova et al. B-Cell Linear Epitopes in the Conservative Regions of Hepatitis C Virus Envelope Glycoproteins
ATE540052T1 (de) Neue peptide, die epitope des humanen herpesvirus 8 darstellen
Jäger Vaccines against NY-ESO-1: Peptides and recombinant viral constructs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, US